UBX: Unity Biotechnology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 28.48
Enterprise Value ($M) 19.58
Book Value ($M) 14.14
Book Value / Share 0.84
Price / Book 2.01
NCAV ($M) -2.73
NCAV / Share -0.16
Price / NCAV -10.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.57
Return on Assets (ROA) -0.33
Return on Equity (ROE) -0.77

Liquidity (mrq)
Quick Ratio 3.45
Current Ratio 3.45

Balance Sheet (mrq) ($M)
Current Assets 30.26
Assets 47.13
Liabilities 32.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Alyeska Investment Group, L.P. 9.99 -0.53

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-17 21,796 120,598 18.07
2025-01-16 30,287 118,660 25.52
2025-01-15 46,972 226,145 20.77
2025-01-14 27,834 325,500 8.55
2025-01-13 94,044 316,250 29.74

(click for more detail)

Similar Companies
TWST – Twist Bioscience Corporation TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc. UTHR – United Therapeutics Corporation
VERV – Verve Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io